Kymos Pharma Services, S.L.

About Kymos Pharma Services, S.L.

KYMOS is a GLP/GMP-certified, GCP compliant, EMA and FDA-inspected European CRO specialized in bioanalysis and CMC. KYMOS provides bioanalytics in EU preclinical & clinical trials for small molecules, biologics and oligonucleotides, PK, full bioequivalence studies and biowaivers for topical products. KYMOS also offers CMC services for method development, batch testing and release, stability testing, biosimilars comparability, characterization of innovators plus years of experience with biopharma clients worldwide. Kymos is headquartered in Barcelona, Spain and has subsidiaries in Germany...

  • ES
  • 2016
    On CPHI since
  • 100 - 249
    Employees
Company types
Contract Service
Contact info
Meet us at

CPHI Frankfurt 2022

Messe Frankfurt, Germany
1-3 November 2022

CPHI Barcelona 2023

Fira Barcelona, Spain
24-26 October 2023

Products from Kymos Pharma Services, S.L. (5)

  • Bioanalysis of Small Molecules

    Product Bioanalysis of Small Molecules

    Kymos Pharma Services, S.L. offers wide range of bionalysis services in medicinal chemistry which includes bioanalysis of small molecules. Kymos offer bioanalytical method development and validation of innovative small molecules by mass spectrometry. It has the experience of being the selected partner for ...
  • Immunogenicity

    Product Immunogenicity

    Kymos Pharma Services, S.L. offers wide range of bionalysis services in medicinal chemistry which includes immunogenicity. Kymos have develops new bioanalytical methods for immunogenicity studies of proteins and peptides following ema and fda guidelines on immunogenicity of therapeutic proteins. Depending ...
  • Method Development, Validation and Transfer

    Product Method Development, Validation and Transfer

    Kymos Pharma Services, S.L. offers wide range of chemistry, manufacturing & control analytical services in medicinal chemistry which includes method development, validation and transfer. Kymos has comprehensive knowledge in the development and validation of analytical proprietary and non-proprietary me...
  • Bioequivalence Studies

    Product Bioequivalence Studies

    Kymos Pharma Services, S.L. offers wide range of bionalysis services in medicinal chemistry which includes bioequivalence studies. Kymos are experts in bioanalysis for bioequivalence studies in collaboration with the sponsor and/or the selected clinical phase center. It has a long list of validated bioanal...
  • Percutaneous Absorption

    Product Percutaneous Absorption

    Kymos Pharma Services, S.L. offers wide range of bionalysis services in medicinal chemistry which includes percutaneous absorption. Kymos shows their experience in studies of percutaneous absorption for topical semisolid drug products using vertical diffusion cells (o franz cells). Both in vitro release te...

Kymos Pharma Services, S.L. Resources (2)

  • News Kymos Acquires Germany’s Prolytic

    Kymos, a Contract Research Organisation (CRO) and member of CataloniaBio & HealthTech, has bought German company Prolytic GmbH in order to strengthen its activity in the biologics and advanced therapies market. The company previously acquired Italian firm Pharmaprogress in 2016.
  • Brochure KYMOS: Adding Value to Biopharma

    KYMOS recently had the pleasure to lead a TV program series about the importance of outsourcing service providers like ourselves in the provision of medicines. Since the outbreak of COVID-19 the general public is paying much more attention to the biopharmaceutical industry and the challenges of conducting drug development, manufacturing, quality control and supply in the midst of a global pandemic. We invite you to watch this 2-minute English video and celebrate society's rising awareness of the key role played by the pharma and biotech sectors in our day-to-day lives.